Santiago Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 311,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "3fca50c7-69ad-4b8b-8d1b-ad1fd0036d8e",
"title": "US STOCKS-Wall Street set for lower open ahead of Powell speech",
"description": "U.S. stock indexes were set to open lower on Tuesday as investors looked ahead to Federal Reserve Chair Jerome Powell's speech, which will be parsed for further clues on how long the central bank will keep interest rates higher. Powell's comments, due at 12:40 p.m. EST (1740 GMT) before the Economic Club of Washington, will be closely monitored after a strong jobs report last week stymied rising hopes of less aggressive monetary policy.",
"keywords": "",
"snippet": "(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.)\n\n*\n\nMicrosoft up on potential ChatGPT investment reveal\n...",
"url": "https://finance.yahoo.com/news/us-stocks-wall-street-set-141718024.html?.tsrc=rss",
"image_url": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
"language": "en",
"published_at": "2023-02-07T14:17:18.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSFTCL.SN",
"name": "MICROSOFT CORP",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 15.989927,
"sentiment_score": 0.4542,
"highlights": [
{
"highlight": ")\n\n*\n\n<em>Microsoft</em> up on potential ChatGPT investment reveal\n\n*\n\nDuPont climbs on strong Q4 profits\n\n*\n\nBoeing up on layoffs announcement\n\n*\n\nFutures down: Dow 0.32%, S&P 0.18%, Nasdaq 0.01%\n\n(Adds comments; updates prices, details)\n\nBy Shubham Batra and Johann M Cherian\n\nFeb 7 (Reuters) -\n\nU.S. stock indexes were set to open lower on Tuesday as investors",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Heavyweight <em>Microsoft</em> <em>Corp</em> added 1.4% in premarket trading. It is expected to reveal its potential investment in chatbot sensation ChatGPT later in the day.\n\nU.S. listed shares of\n\nBaidu Inc\n\nsoared 11.7% as the Chinese search engine said it would conclude the testing of its ChatGPT-style project 'Ernie Bot' in March.",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "755bf7f2-d8b9-42d5-8e88-2d5fa07f17a9",
"title": "Jim Cramer's top 10 things to watch in the market Tuesday: Fedspeak, video games, memesters",
"description": "The Dow, the S&P 500 and the Nasdaq are headed for a muted open ahead of Fed Chairman Jerome Powell's lunchtime speech",
"keywords": "Foot Locker Inc, Chegg Inc, Molson Coors Beverage Co, Constellation Brands Inc, Hertz Global Holdings Inc, Dupont De Nemours Inc, Boeing Co, Pinterest Inc, NASDAQ Composite, S&P 500 Index, Dow Jones Industrial Average, Jerome Powell, Bed Bath & Beyond Inc, Microsoft Corp, Take-Two Interactive Software Inc, Activision Blizzard Inc, Jim Cramer, Investment strategy, Markets, Breaking News: Markets, business news",
"snippet": "My top 10 things to watch Tuesday, Feb. 7 1. The Dow , the S & P 500 and the Nasdaq are headed for a muted open ahead of Fed Chairman Jerome Powell's lunchtime ...",
"url": "https://www.cnbc.com/2023/02/07/jim-cramers-top-10-things-tuesday-fedspeak-video-games-memesters.html",
"image_url": "https://image.cnbcfm.com/api/v1/image/107187586-16752822402023-02-01t200603z_1657693998_rc2j2z9f5c50_rtrmadp_0_usa-fed-stocks.jpeg?v=1675779059&w=1920&h=1080",
"language": "en",
"published_at": "2023-02-07T14:10:59.000000Z",
"source": "cnbc.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 20.54221,
"sentiment_score": -0.8126,
"highlights": [
{
"highlight": "<em>Morgan</em> <em>Stanley</em> rates Molson Coors (TAP) an equal weight or hold. Don't know if the beer maker can grow sustainability. We like and own Constellation Brands (STZ) for its Mexican beer portfolio. 9. Chegg (CHGG) reports a terrible quarter but they couldn't bear to say it. The learning platform actually blamed the lack of rigor in classes.",
"sentiment": -0.8126,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "d6645d34-8ffa-4cca-b5c0-c57bc1e14951",
"title": "Dividend Capture Strategy: 10 High-Yield Stocks to Buy in February",
"description": "In this article, we discuss 10 high-yield stocks to buy in February. You can skip our detailed analysis on dividend capture strategy and past performance of high dividend stocks, and go directly to read Dividend Capture Strategy: 5 High-Yield Stocks to Buy in February. Dividend capture strategy is one of the most popular techniques employed […]",
"keywords": "",
"snippet": "In this article, we discuss 10 high-yield stocks to buy in February. You can skip our detailed analysis on dividend capture strategy and past performance of hig...",
"url": "https://finance.yahoo.com/news/dividend-capture-strategy-10-high-140741082.html?.tsrc=rss",
"image_url": "https://media.zenfs.com/en/insidermonkey.com/3e2998b6f10afcbdeff233440f80e8eb",
"language": "en",
"published_at": "2023-02-07T14:07:41.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "CVX.SN",
"name": "Chevron Corporation",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Energy",
"match_score": 28.42597,
"sentiment_score": 0.63768,
"highlights": [
{
"highlight": "<em>Chevron</em> <em>Corporation</em> (NYSE:CVX)\n\nEx-Dividend Date: February 15\n\nDividend Yield as of February 6: 3.56%\n\nAn American energy company, <em>Chevron</em> <em>Corporation</em> (NYSE:CVX) is another high-yield dividend stock on our list. In January 2023, the company declared a 36th consecutive dividend hike which took its quarterly dividend to $1.51 per share.",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Truist raised its price target on <em>Chevron</em> <em>Corporation</em> (NYSE:CVX) in January to $179 and maintained a Hold rating on the shares, appreciating the company’s recently announced repurchase authorization worth $75 billion.",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "In the fourth quarter of 2022, <em>Chevron</em> <em>Corporation</em> (NYSE:CVX) reported revenue of $56.4 billion, which showed a 17.3% growth from the same period last year. In FY22, it reported an operating cash flow of $49.6 billion and its free cash flow came in at $37.6 billion.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "The number of hedge funds tracked by Insider Monkey owning stakes in <em>Chevron</em> <em>Corporation</em> (NYSE:CVX) grew to 66 in Q3 2022, from 59 in the previous quarter. These stakes have a total value of over $27 billion.\n\nDiamond Hill Capital mentioned <em>Chevron</em> <em>Corporation</em> (NYSE:CVX) in its Q1 2022 investor letter.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Here is what the firm had to say:\n\n“Other top contributors in Q1 included multinational energy company <em>Chevron</em> Corp. (NYSE:CVX). The company benefited from increased energy demand as COVID-related economic restrictions eased in tandem with concerns regarding supply interruptions related to Russia’s invasion of Ukraine.”\n\n6.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "KO.SN",
"name": "The Coca-Cola Company",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 32.716812,
"sentiment_score": 0.343467,
"highlights": [
{
"highlight": "Some examples of such stocks are <em>The</em> <em>Coca</em>-<em>Cola</em> <em>Company</em> (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG). Further in this article, we will discuss high-yield stocks to buy in February.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to <em>The</em> <em>Coca</em>-<em>Cola</em> <em>Company</em> (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG), investors are also loading up on International Business Machines Corporation (NYSE:IBM) due to the company's dividend growth streak.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "The company can be added to dividend portfolios alongside popular dividend stocks like <em>The</em> <em>Coca</em>-<em>Cola</em> <em>Company</em> (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG).\n\nWalgreens Boots Alliance, Inc. (NASDAQ:WBA) posted a revenue of $33.3 billion, which beat Street estimates by $340 million.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "XOM.SN",
"name": "Exxon Mobil Corporation",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Energy",
"match_score": 44.608555,
"sentiment_score": 0.616825,
"highlights": [
{
"highlight": "<em>Exxon</em> <em>Mobil</em> <em>Corporation</em> (NYSE:XOM)\n\nEx-Dividend Date: February 13\n\nDividend Yield as of February 6: 3.27%\n\n<em>Exxon</em> <em>Mobil</em> <em>Corporation</em> (NYSE:XOM) specializes in the distribution of oil and natural gas. The company is headquartered in Texas, US. In FY22, the company's cash position remained strong with an operating cash flow of $76.8 billion.",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "On January 31, <em>Exxon</em> <em>Mobil</em> <em>Corporation</em> (NYSE:XOM) declared a quarterly dividend of $0.91 per share. The company holds a 40-year track record of consistent dividend growth. The stock's dividend yield on February 6 came in at 3.27%. This high-yield dividend stock's ex-dividend date is February 13.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "In February, Argus raised its price target on <em>Exxon</em> <em>Mobil</em> <em>Corporation</em> (NYSE:XOM) to $133 with a Buy rating on the shares, highlighting the company's recent quarterly earnings. The firm also appreciated the company's overall performance in 2022.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "As of the close of Q3 2022, 75 hedge funds tracked by Insider Monkey owned stakes in <em>Exxon</em> <em>Mobil</em> <em>Corporation</em> (NYSE:XOM), up from 72 in the previous quarter. The collective value of these stakes is $5.5 billion. GQG Partners owned the largest stake in the company, worth nearly $3 billion.",
"sentiment": 0.5106,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PG.SN",
"name": "The Procter & Gamble Company",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 36.882042,
"sentiment_score": 0.343467,
"highlights": [
{
"highlight": "Some examples of such stocks are The Coca-Cola Company (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and <em>The</em> <em>Procter</em> & <em>Gamble</em> <em>Company</em> (NYSE:PG). Further in this article, we will discuss high-yield stocks to buy in February.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to The Coca-Cola Company (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and <em>The</em> <em>Procter</em> & <em>Gamble</em> <em>Company</em> (NYSE:PG), investors are also loading up on International Business Machines Corporation (NYSE:IBM) due to the company's dividend growth streak.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "The company can be added to dividend portfolios alongside popular dividend stocks like The Coca-Cola Company (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and <em>The</em> <em>Procter</em> & <em>Gamble</em> <em>Company</em> (NYSE:PG).\n\nWalgreens Boots Alliance, Inc. (NASDAQ:WBA) posted a revenue of $33.3 billion, which beat Street estimates by $340 million.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "8cfd0a36-117a-4db9-a467-464fa81396b9",
"title": "There Are Very Strange Things Going On at Goldman Sachs",
"description": "By Pam Martens and Russ Martens: February 7, 2023 ~ Goldman Sachs’ online bank, Marcus, is offering an interest rate on its savings accounts that is 350",
"keywords": "",
"snippet": "By Pam Martens and Russ Martens: February 7, 2023 ~\n\nGoldman Sachs’ online bank, Marcus, is offering an interest rate on its savings accounts that is 350 time...",
"url": "https://wallstreetonparade.com/2023/02/there-are-very-strange-things-going-on-at-goldman-sachs/",
"image_url": "https://wallstreetonparade.com/wp-content/uploads/2023/02/Savings-Accounts-Interest-Rates.jpg",
"language": "en",
"published_at": "2023-02-07T14:04:41.000000Z",
"source": "wallstreetonparade.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 17.064,
"sentiment_score": 0.8158,
"highlights": [
{
"highlight": "The market value of the venerable 154-year-old investment bank, at $121bn, is now $42bn less than its longtime arch-rival <em>Morgan</em> <em>Stanley</em>. It used to be that Goldman was the more valuable bank for many years.” (“Venerable” is an interesting choice of words for Cohan to use to describe Goldman Sachs.",
"sentiment": 0.8158,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "5c937a2b-a70f-4247-9bc3-df9da0a57e83",
"title": "Lebenthal Global Advisors, LLC Buys 3, Sells 2 in 4th Quarter",
"description": "GuruFocus Article or News written by insider and the topic is about:",
"keywords": "GuruFocus, Article, News, insider, VCIT, JPST, MUB, XLY, IWR",
"snippet": "Lebenthal Global Advisors, LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.\n\nThe 13F report details which stocks w...",
"url": "https://www.gurufocus.com/news/1944491/lebenthal-global-advisors-llc-buys-3-sells-2-in-4th-quarter",
"image_url": "https://static.gurufocus.com/images/logo_global.png",
"language": "en",
"published_at": "2023-02-07T14:00:07.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "IWR.SN",
"name": "iShares Russell Mid-Cap ETF",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 66.07442,
"sentiment_score": 0.53805,
"highlights": [
{
"highlight": "On 02/07/2023, <em>iShares</em> <em>Russell</em> <em>Mid</em>-<em>Cap</em> <em>ETF</em> traded for a price of $73.48 per share and a market cap of $29.35Bil. The stock has returned -2.68% over the past year.\n\nThere is insufficient data to calculate the stock’s financial strength and profitability ratings.",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "In terms of valuation, <em>iShares</em> <em>Russell</em> <em>Mid</em>-<em>Cap</em> <em>ETF</em> has a price-earnings ratio of 17.28 and a price-book ratio of 2.80.\n\nPlease note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "72265fa5-0a85-45f2-a787-f65989496659",
"title": "Brookmont Capital Management Buys 3, Sells 2 in 4th Quarter",
"description": "GuruFocus Article or News written by insider and the topic is about:",
"keywords": "GuruFocus, Article, News, insider, GILD, EMN, SHEL, ABT, CVX",
"snippet": "Brookmont Capital Management recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.\n\nThe 13F report details which stocks wer...",
"url": "https://www.gurufocus.com/news/1944488/brookmont-capital-management-buys-3-sells-2-in-4th-quarter",
"image_url": "https://static.gurufocus.com/images/logo_global.png",
"language": "en",
"published_at": "2023-02-07T14:00:05.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABT.SN",
"name": "Abbott Laboratories",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 28.995516,
"sentiment_score": 0.6719,
"highlights": [
{
"highlight": "On 02/07/2023, <em>Abbott</em> <em>Laboratories</em> traded for a price of $110.75 per share and a market cap of $193.10Bil. The stock has returned -13.14% over the past year.\n\nGuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "In terms of valuation, <em>Abbott</em> <em>Laboratories</em> has a price-earnings ratio of 28.32, a price-book ratio of 5.41, a price-earnings-to-growth (PEG) ratio of 1.30, a EV-to-Ebitda ratio of 17.01 and a price-sales ratio of 4.48.\n\nThe price-to-GF Value ratio is 0.85, earning the stock a GF Value rank of 9.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABTCL.SN",
"name": "Abbott Laboratories",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 28.995516,
"sentiment_score": 0.6719,
"highlights": [
{
"highlight": "On 02/07/2023, <em>Abbott</em> <em>Laboratories</em> traded for a price of $110.75 per share and a market cap of $193.10Bil. The stock has returned -13.14% over the past year.\n\nGuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "In terms of valuation, <em>Abbott</em> <em>Laboratories</em> has a price-earnings ratio of 28.32, a price-book ratio of 5.41, a price-earnings-to-growth (PEG) ratio of 1.30, a EV-to-Ebitda ratio of 17.01 and a price-sales ratio of 4.48.\n\nThe price-to-GF Value ratio is 0.85, earning the stock a GF Value rank of 9.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "be52615f-1915-4443-8e27-805c5efd4d75",
"title": "Global Acne Medication Market to generate USD 14.26 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting",
"description": "Urbanization and industrialization lead to emission of various types of airborne pollutants such as PAHs, VOCs, and NOx that worsen acne symptoms such as...",
"keywords": "Next Move Strategy Consulting, Oral antibiotics, Acne Medication Market, Acne Vulgaris Industry, Benzoyl Peroxide, Pharmacies, Drug, Prescription Medicines, SkinCare",
"snippet": "New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- According to a report published by Next Move Strategy Consulting, the Acne Medication Market generated USD 10.08 bil...",
"url": "https://www.globenewswire.com/news-release/2023/02/07/2603085/0/en/Global-Acne-Medication-Market-to-generate-USD-14-26-Billion-by-2030-Outlines-a-New-Report-by-Next-Move-Strategy-Consulting.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/902cab86-11f5-4b78-ba3c-caa6b411ed82?size=1",
"language": "en",
"published_at": "2023-02-07T14:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 11.507768,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Johnson & Johnson, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.507768,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Johnson & Johnson, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "91b6d483-8a5b-4166-897e-da72b3bba3e9",
"title": "Molson Coors draws cautious first ratings look from Morgan Stanley",
"description": "Morgan Stanley started off coverage on Molson Coors Beverage Company (TAP) with an Equal-weight rating. Read more.",
"keywords": "",
"snippet": "Morgan Stanley started off coverage on Molson Coors Beverage Company (NYSE:TAP) with an Equal-weight rating.\n\nAnalyst Eric Serotta warned that sustainable top l...",
"url": "https://seekingalpha.com/news/3932833-molson-coors-draws-cautious-first-ratings-look-from-morgan-stanley",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/77240291/image_77240291.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2023-02-07T13:59:55.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 102.16454,
"sentiment_score": 0.139867,
"highlights": [
{
"highlight": "<em>Morgan</em> <em>Stanley</em> started off coverage on Molson Coors Beverage Company (NYSE:TAP) with an Equal-weight rating.\n\nAnalyst Eric Serotta warned that sustainable top line growth for Molson Coors (TAP) is likely to remain elusive due to structurally challenged segment exposure.",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Morgan</em> <em>Stanley</em> assigned a price target of $51 to TAP.\n\nShares of Molson Coors (TAP) fell 0.52% premarket to $53.30.\n\nSector update: Beer and spirits sales may be on the downswing - watch these stocks",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Molson Coors draws cautious first ratings look from <em>Morgan</em> <em>Stanley</em>",
"sentiment": -0.1027,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "ef0ae657-82ba-44b3-84e3-8de4beaec194",
"title": "Retail investors flock to small-cap AI firms as Big Tech battles for share",
"description": "Retail investors are piling into small-cap firms that employ artificial intelligence amid intensifying competition between tech titans Google parent Alphabet and Microsoft to secure leadership in the next big driver of growth. The $3-billion AI software firm C3.ai was the fifth most actively traded on Fidelity's platform for small investors on Monday, while drawing record daily retail inflows worth $31.4 million, as per Vanda Research.",
"keywords": "",
"snippet": "By Medha Singh\n\n(Reuters) - Retail investors are piling into small-cap firms that employ artificial intelligence amid intensifying competition between tech tita...",
"url": "https://finance.yahoo.com/news/retail-investors-flock-small-cap-135856468.html?.tsrc=rss",
"image_url": "https://media.zenfs.com/en/reuters-finance.com/1996a3a411651c8c7a9578266b4ee39e",
"language": "en",
"published_at": "2023-02-07T13:58:56.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOGL.SN",
"name": "Alphabet Inc.",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Communication Services",
"match_score": 20.316158,
"sentiment_score": 0.7323,
"highlights": [
{
"highlight": "By Medha Singh\n\n(Reuters) - Retail investors are piling into small-cap firms that employ artificial intelligence amid intensifying competition between tech titans Google parent <em>Alphabet</em> and Microsoft to secure leadership in the next big driver of growth.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "Google-owner <em>Alphabet</em> <em>Inc</em> on Monday said it would launch a chatbot service Bard and more artificial intelligence for its search engine as well as developers.",
"sentiment": 0.6682,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOG.SN",
"name": "Alphabet Inc.",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Communication Services",
"match_score": 20.316158,
"sentiment_score": 0.7323,
"highlights": [
{
"highlight": "By Medha Singh\n\n(Reuters) - Retail investors are piling into small-cap firms that employ artificial intelligence amid intensifying competition between tech titans Google parent <em>Alphabet</em> and Microsoft to secure leadership in the next big driver of growth.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "Google-owner <em>Alphabet</em> <em>Inc</em> on Monday said it would launch a chatbot service Bard and more artificial intelligence for its search engine as well as developers.",
"sentiment": 0.6682,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOGCL.SN",
"name": "Alphabet Inc.",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 20.316158,
"sentiment_score": 0.7323,
"highlights": [
{
"highlight": "By Medha Singh\n\n(Reuters) - Retail investors are piling into small-cap firms that employ artificial intelligence amid intensifying competition between tech titans Google parent <em>Alphabet</em> and Microsoft to secure leadership in the next big driver of growth.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "Google-owner <em>Alphabet</em> <em>Inc</em> on Monday said it would launch a chatbot service Bard and more artificial intelligence for its search engine as well as developers.",
"sentiment": 0.6682,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "d9f597b7-4a8f-4d89-abf8-4b3344218c96",
"title": "Osteoporosis Treatment Market Size Growing at 3.9% CAGR, Set to Reach USD 17.1 Billion By 2030",
"description": "Acumen Research and Consulting recently published report titled “Osteoporosis Treatment Market and Region Forecast, 2022 - 2030”...",
"keywords": "Acumen Research and Consulting, Osteoporosis Treatment Market, Osteoporosis Treatment Size, Osteoporosis Treatment Share, Osteoporosis Treatment CAGR",
"snippet": "LOS ANGELES, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The Global Osteoporosis Treatment Market Size gathered USD 12.2 Billion in 2021 and is set to garner a market siz...",
"url": "https://www.globenewswire.com/news-release/2023/02/07/2603069/0/en/Osteoporosis-Treatment-Market-Size-Growing-at-3-9-CAGR-Set-to-Reach-USD-17-1-Billion-By-2030.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/908452c1-dc89-4765-93b2-c92a8f7b6f2d?size=1",
"language": "en",
"published_at": "2023-02-07T13:52:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 14.414289,
"sentiment_score": -0.016933,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Novartis AG, Eli Lilly and Company, and GlaxoSmithKline plc, among others.\n\nOsteoporosis Treatment Market Overview\n\nThe market for osteoporosis treatment has witnessed a decent surge in demand in recent years, owing to the increasing prevalence of the condition globally.",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Hoffmann-La Roche Ltd, GSK plc., Ligand Pharmaceuticals Incorporated, Merck & Co., Inc., Novartis AG, <em>Pfizer</em> <em>Inc</em>., Teva Pharmaceutical Industries Ltd., and Viatris Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Buy this premium research report –\n\nhttps://www.acumenresearchandconsulting.com/buy-now/0/3130\n\nOsteoporosis Treatment Market Key Players\n\nThe Osteoporosis Treatment Market is characterized by a large number of players, including Amgen, Roche, Merck, <em>Pfizer</em>, Sanofi, Eli Lilly, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries, Biogen, AbbVie",
"sentiment": 0.0772,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.SN",
"name": "Merck & Co., Inc.",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.947466,
"sentiment_score": 0.025733,
"highlights": [
{
"highlight": "The market is dominated by major pharmaceutical companies, including <em>Merck</em> & <em>Co</em>., <em>Inc</em>., Pfizer Inc., Novartis AG, Eli Lilly and Company, and GlaxoSmithKline plc, among others.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Hoffmann-La Roche Ltd, GSK plc., Ligand Pharmaceuticals Incorporated, <em>Merck</em> & <em>Co</em>., <em>Inc</em>., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Buy this premium research report –\n\nhttps://www.acumenresearchandconsulting.com/buy-now/0/3130\n\nOsteoporosis Treatment Market Key Players\n\nThe Osteoporosis Treatment Market is characterized by a large number of players, including Amgen, Roche, <em>Merck</em>, Pfizer, Sanofi, Eli Lilly, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries, Biogen, AbbVie",
"sentiment": 0.0772,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.414289,
"sentiment_score": -0.016933,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Novartis AG, Eli Lilly and Company, and GlaxoSmithKline plc, among others.\n\nOsteoporosis Treatment Market Overview\n\nThe market for osteoporosis treatment has witnessed a decent surge in demand in recent years, owing to the increasing prevalence of the condition globally.",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Hoffmann-La Roche Ltd, GSK plc., Ligand Pharmaceuticals Incorporated, Merck & Co., Inc., Novartis AG, <em>Pfizer</em> <em>Inc</em>., Teva Pharmaceutical Industries Ltd., and Viatris Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Buy this premium research report –\n\nhttps://www.acumenresearchandconsulting.com/buy-now/0/3130\n\nOsteoporosis Treatment Market Key Players\n\nThe Osteoporosis Treatment Market is characterized by a large number of players, including Amgen, Roche, Merck, <em>Pfizer</em>, Sanofi, Eli Lilly, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries, Biogen, AbbVie",
"sentiment": 0.0772,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "SSE",
"total_documents": 576,
"sentiment_avg": 0.2994867154666567
}
]
}
Other details
Country
- cl
- 3,319